Guided Therapeutics Inc (GTHP) stock
GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$0.16−0.03 (-15.79%)
Close on Oct 19, 2026Market cap $15.45MP/E –Yield –
Guided Therapeutics cash
Cash and short-term investments held at the end of each period.
Guided Therapeutics's cash was $12.00K at Jun 30, 2026. For fiscal 2025 it was $63.00K, down 83.8% from the year before. Over ten years it grew 6.1% a year on average. The highest annual figure on record is $3.27M in fiscal 2010.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $63.00K | -83.8% |
| FY2024 | Dec 31, 2024 | $388.00K | -34.3% |
| FY2023 | Dec 31, 2023 | $591.00K | -74.4% |
| FY2022 | Dec 31, 2022 | $2.31M | +259.7% |
| FY2021 | Dec 31, 2021 | $643.00K | +253.3% |
| FY2020 | Dec 31, 2020 | $182.00K | -79.8% |
| FY2019 | Dec 31, 2019 | $899.00K | – |
| FY2018 | Dec 31, 2018 | $0 | -100.0% |
| FY2017 | Dec 31, 2017 | $1.00K | -92.9% |
| FY2016 | Dec 31, 2016 | $14.00K | -60.0% |
| FY2015 | Dec 31, 2015 | $35.00K | -78.4% |
| FY2014 | Dec 31, 2014 | $162.00K | -73.6% |
| FY2013 | Dec 31, 2013 | $613.00K | -41.3% |
| FY2012 | Dec 31, 2012 | $1.05M | -52.5% |
| FY2011 | Dec 31, 2011 | $2.20M | -32.7% |
| FY2010 | Dec 31, 2010 | $3.27M | +1320.9% |
| FY2009 | Dec 31, 2009 | $230.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $12.00K | -93.5% |
| Q1 FY2026 | Mar 31, 2026 | $369.00K | +220.9% |
| Q4 FY2025 | Dec 31, 2025 | $63.00K | -83.8% |
| Q3 FY2025 | Sep 30, 2025 | $87.00K | -55.2% |
| Q2 FY2025 | Jun 30, 2025 | $185.00K | -32.7% |
| Q1 FY2025 | Mar 31, 2025 | $115.00K | -74.2% |
| Q4 FY2024 | Dec 31, 2024 | $388.00K | -34.3% |
| Q3 FY2024 | Sep 30, 2024 | $194.00K | -73.5% |
| Q2 FY2024 | Jun 30, 2024 | $275.00K | -79.7% |
| Q1 FY2024 | Mar 31, 2024 | $445.00K | -75.8% |
| Q4 FY2023 | Dec 31, 2023 | $591.00K | -74.4% |
| Q3 FY2023 | Sep 30, 2023 | $731.00K | -72.9% |
| Q2 FY2023 | Jun 30, 2023 | $1.36M | +204.5% |
| Q1 FY2023 | Mar 31, 2023 | $1.84M | +153.4% |
| Q4 FY2022 | Dec 31, 2022 | $2.31M | +259.7% |
| Q3 FY2022 | Sep 30, 2022 | $2.70M | +398.5% |
| Q2 FY2022 | Jun 30, 2022 | $446.00K | -51.6% |
| Q1 FY2022 | Mar 31, 2022 | $725.00K | -41.9% |
| Q4 FY2021 | Dec 31, 2021 | $643.00K | +253.3% |
| Q3 FY2021 | Sep 30, 2021 | $541.00K | -6.9% |
| Q2 FY2021 | Jun 30, 2021 | $922.00K | +20.8% |
| Q1 FY2021 | Mar 31, 2021 | $1.25M | +5838.1% |
| Q4 FY2020 | Dec 31, 2020 | $182.00K | -79.8% |
| Q3 FY2020 | Sep 30, 2020 | $581.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $763.00K | – |
| Q1 FY2020 | Mar 31, 2020 | $21.00K | +250.0% |
| Q4 FY2019 | Dec 31, 2019 | $899.00K | – |
| Q3 FY2019 | Sep 30, 2019 | $0 | -100.0% |
| Q2 FY2019 | Jun 30, 2019 | $0 | -100.0% |
| Q1 FY2019 | Mar 31, 2019 | $6.00K | -92.1% |
| Q4 FY2018 | Dec 31, 2018 | $0 | -100.0% |
| Q3 FY2018 | Sep 30, 2018 | $70.00K | -5.4% |
| Q2 FY2018 | Jun 30, 2018 | $41.00K | +412.5% |
| Q1 FY2018 | Mar 31, 2018 | $76.00K | +7500.0% |
| Q4 FY2017 | Dec 31, 2017 | $1.00K | -92.9% |
| Q3 FY2017 | Sep 30, 2017 | $74.00K | +1750.0% |
| Q2 FY2017 | Jun 30, 2017 | $8.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $1.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $14.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $4.00K | – |
See a number that looks wrong?